ESR 3: Mitja Maximilian Zdouc
Bio prospecting, compound screening, identification and structural characterization of bioactive molecules
Mitja will perform research in antibacterial drug discovery. The aim of the project is the identification and characterization of novel microbial metabolites with antibiotic activity.
Mitja’s work will involve the identification of new compounds exploiting Naicons’ large collection of actinomycetes strains. Furthermore, the characterization of active extracts will lead to the isolation of the bioactive compounds and to their structural elucidation. Novel compounds will be further characterized for their in vitro antimicrobial spectrum and other properties.
Naicons Srl, Microbiology, Italy
Dr. Margherita Sosio (Naicons)
Prof. Tanneke den Blaauwen (UvA)
Prof. Waldemar Vollmer (UNEW)
Mitja was born in Austria in 1992. He received his Master of Pharmacy in 2016 at the University Vienna, Austria. The research for his diploma thesis was done during an Erasmus+ internship in Slovenia, at both the Universities of Primorska and Ljubljana. There, he participated in various drug discovery projects via virtual screening on bacterial enzymes, for example PBP2a from S. aureus and InhA from M. tuberculosis. The experiences he gained during his stay led to his decision to further pursue a career in antibacterial drug research. He graduated with the thesis titled “Docking Studies on Bacterial Enzymes MurD and PBP2a”. His work was honoured “best thesis in pharmaceutical chemistry in 2016” by the Austrian Pharmaceutical Society.
Science Slam on drug discovery created by Mitja